Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Clement, DE
Albrecht Clement, Vaihingen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110082622 | METHOD AND DEVICE FOR DIAGNOSING THE DYNAMICS OF AN EXHAUST GAS SENSOR - The invention relates to a method for diagnosing the dynamics of an exhaust gas sensor embodied as a lambda probe, which is disposed in an exhaust gas duct of an internal combustion engine in the direction of flow of the exhaust gas upstream or downstream of a catalytic converter and with which the air/fuel ratio of the gas mixture supplied to the internal combustion engine is controlled via a control circuit. During the diagnosis, provision is made in the method according to the invention for at least one actuator intervention to be specified by means of a control algorithm of a diagnostic controller specifically in the direction of an asymmetric behavior, which is achieved by an extension of one of the two ramps, until the actuator intervention is compensated by a possible asymmetric dynamic error of the exhaust gas sensor, a reaction to said actuator intervention being used as the criterion for assessing an asymmetric dynamic error of said exhaust gas sensor. The device for carrying out the method provides that a diagnostic device, which is connected to the exhaust gas sensor, includes a diagnostic controller, with which during the diagnosis at least one actuator intervention can be specified specifically in the direction of an asymmetric behavior and the presence, respectively the extent, of the asymmetric dynamic error of said exhaust gas sensor can be detected from the measurement of the intervention when said intervention is being compensated due to a possible asymmetric dynamic error of said exhaust gas sensor. Even small asymmetric dynamic errors of the exhaust gas sensor, which can be embodied as a two point or as a wideband lambda probe, can especially be quickly and reliably detected with the method and the device for carrying out said method; thus contributing to improved on-board diagnostics. | 04-07-2011 |
Alf Clement, Gartringen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110131000 | CHIP TESTER, METHOD FOR PROVIDING TIMING INFORMATION, TEST FIXTURE SET, APPARATUS FOR POST-PROCESSING PROPAGATION DELAY INFORMATION, METHOD FOR POST-PROCESSING DELAY INFORMATION, CHIP TEST SET UP AND METHOD FOR TESTING DEVICES UNDER TEST - A chip tester for testing at least two devices under test connected to the chip tester has a timing calculator for generating a timing information for the channels of the chip tester. The timing calculator is adapted to obtain a propagation delay difference information describing a difference between, on the one hand, a propagation delay from the first channel port of the chip tester to the first terminal of the first device under test and, on the other hand, a propagation delay from the first channel port of the chip tester to the second terminal of the second device under test. The timing calculator is adapted to provide a timing information for a second channel of the chip tester connected to the first device under test or to the second device under test on the basis of the propagation delay difference information. The channel module configurator is adapted to configure the second channel of the chip tester on the basis of the timing information. | 06-02-2011 |
Bernd Clement, Kiel DE
| Patent application number | Description | Published |
|---|---|---|
| 20080261998 | Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors - The present invention relates to novel compounds for inhibiting the urokinase plasminogen activator (uPA), which have high bioavailability and oral administerability, and also to the use thereof as therapeutic active compounds for the treatment of urokinase- or/and urokinase receptor-associated disorders such as, for example, tumors and metastasizing. The invention relates in particular to compounds containing hydroxyamidine or hydroxyguanidine groups. | 10-23-2008 |
| 20090270440 | BIOAVAILABILITY OF ACTIVE SUBSTANCES HAVING AN AMIDINE FUNCTION IN MEDICAMENTS - The invention relates to the use of N,N′-dihydroxyamidine (I), N,N′-dihydroxyamidine ether (II), N,N′-dihydroxyamidine diether (III), N,N′-dihydroxyamidine ester (IV), N,N′-dihydroxyamidine diester (V) or 4-hydroxy-1,2,4-oxadiazoline (VI) of the formulae cited above, wherein R represents hydrogen, an alkyl and/or aryl radical, as a substitute for an amidine function of a medicament for improving the bioavailability of the medicament. | 10-29-2009 |
| 20100068272 | HYDROXYAMIDINE AND HYDROXYGUANIDINE COMPOUNDS AS UROKINASE INHIBITORS - The present invention relates to novel compounds for inhibiting the urokinase plasminogen activator (uPA), which have high bioavailability and oral administerability, and also to the use thereof as therapeutic active compounds for the treatment of urokinase- or/and urokinase receptor-associated disorders such as, for example, tumors and metastasizing. The invention relates in particular to compounds containing hydroxyamidine or hydroxyguanidine groups. | 03-18-2010 |
| 20100234641 | Basic Acetophenones as Inhibitors of No-Synthases - Use of the substance characterized by general structural formula (I) | 09-16-2010 |
| 20110021835 | AMINO ACID DERIVATIVES USED AS PHARMACEUTICAL SUBSTANCES - The invention relates to a method for improving bioavailability of pharmaceutical substances and for allowing the pharmaceutical substances to permeate the blood-brain barrier, the pharmaceutical substances having at least one or more amidine, guanidine, N-hydroxyamidine (amidoxime) or N-hydroxyguanidine functions. The invention also relates to medicaments containing the correspondingly modified pharmaceutical substances. | 01-27-2011 |
| 20110028756 | USE OF AMIDOXIME CARBOXYLIC ACID ESTERS AND N-HYDROXYGUANIDINE CARBOXYLIC ACID ESTERS FOR PRODUCING PRODRUGS - The invention relates to a method for improving the bioavailability of pharmaceutical substances and for allowing the pharmaceutical substances to permeate the blood-brain barrier, the pharmaceutical substances having at least one or more amidine, guanidine, N-hydroxyamidine (amidoxime) or N-hydroxyguanidine functions. The invention also relates to medicaments containing the correspondingly modified pharmaceutical substances. | 02-03-2011 |
Florian Clement, Freiburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20110139241 | SOLAR CELL AND METHOD FOR PRODUCING A SOLAR CELL - A solar cell and to a method for producing a solar cell is provided. The solar cell includes a semi-conductor substrate with doped regions ( | 06-16-2011 |
| 20110155239 | SOLAR CELL AND METHOD FOR THE PRODUCTION THEREOF - A solar cell having a semiconductor substrate with a front face and a rear face extending substantially parallel thereto, a front face metallization, a rear face metallization and at least three doped regions having at least two different conductivity types, including: a first doped region with a first conductivity type located on the front face of the semiconductor substrate and extends substantially over the entire front face; a second doped region with the opposite conductivity type to that of the first conductivity type located on the rear face and extends partially over said face; and a third doped region with the first conductivity type located on the rear face and extends partially over said face. The front face metallization is connected to the first doped region and the rear face metallization is connected to the second doped region in an electrically conductive manner and the solar cell has an electrically conductive connection which connects the third doped region to the front face metallization and/or the first doped region. | 06-30-2011 |
Juergen Clement, Rostock DE
| Patent application number | Description | Published |
|---|---|---|
| 20080236470 | Floating structure - The invention is related to a floatable structure as a rigid unit for carrying loads and especially to such a structure which is composed of floatable single bodies being connected by longitudinal connecting members provided with cavities. | 10-02-2008 |
Reiner Clement, Amstetten DE
| Patent application number | Description | Published |
|---|---|---|
| 20080252876 | System for Measuring the Image Quality of an Optical Imaging System - A measuring system ( | 10-16-2008 |
| 20100315651 | SYSTEM FOR MEASURING THE IMAGE QUALITY OF AN OPTICAL IMAGING SYSTEM - A measuring system for the optical measurement of an optical imaging system, which is provided to image a pattern arranged in an object surface of the imaging system in an image surface of the imaging system, comprises an object-side structure carrier having an object-side measuring structure, to be arranged on the object side of the imaging system; an image-side structure carrier having an image-side measuring structure, to be arranged on the image side of the imaging system; the object-side measuring structure and the image-side measuring structure being matched to each other in such a way that, when the object-side measuring structure is imaged onto the image-side measuring structure with the aid of the imaging system, a superposition pattern is produced; and a detector for the locally resolving acquisition of the superposition pattern. The imaging system is designed as an immersion system for imaging with the aid of an immersion liquid. A structure carrier to be arranged in the region of the immersion liquid is assigned a protective system in order to increase the resistance of the measuring structure to degradation caused by the immersion liquid. A measurement of immersion systems under immersion conditions is thereby possible without detrimental influence of the immersion liquid on the measuring accuracy. | 12-16-2010 |
Ulrich Clement, Puchheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20080261334 | Method of Processing Semiconductor Wafers - A method of processing semiconductor waters comprises forming a pattern of recesses in an exposed surface of each water in a lot, prior to an epitaxy step. At least one recessed test structure is included in the pattern of recesses. At least one dimension of the recessed test structure is determined prior to the epitaxy step, then a corresponding dimension of an epitaxial structure grown above the recessed test structure in the epitaxy step is measured. A deviation between the dimension of the recessed test structure and the dimension of the epitaxial structure is determined and, from the deviation, the process temperature at which the epitaxy step was performed is determined. In case the deviation exceeds a predetermined limit, the temperature in the process chamber is adjusted for a subsequent lot of waters to be processed. | 10-23-2008 |